Please login to the form below

Not currently logged in
Email:
Password:

MSD

This page shows the latest MSD news and features for those working in and with pharma, biotech and healthcare.

MSD and AstraZeneca announce phase 3 results for prostate cancer therapy

MSD and AstraZeneca announce phase 3 results for prostate cancer therapy

MSD – known as Merck &Co in the US and Canada – and AstraZeneca have shared positive results from the PROpel phase 3 trial for the combination therapy of Lynparza (olaparib) plus abiraterone

Latest news

More from news
Approximately 81 fully matching, plus 405 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 4 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 51 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....